Financial comparisons Laboratorios Farmaceuticos Rovi, S.A.
Stocks
ROVI
ES0157261019
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 57.40 EUR | -0.17% |
|
-3.37% | -9.61% |
| 13/05 | Spanish stocks - Factors to watch on May 13 | RE |
| 09/05 | Laboratorios Farmaceuticos Rovi, S.A., Q1 2026 Earnings Call, May 06, 2026 |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
 | 87Cr | 18.89% | 24.99% | 22.72% | 14.7% | 0.11x | |
| 6.52TCr | 31.67% | 41.84% | 106.69% | 22.77% | 1.2x | |
| 9.42TCr | 28.46% | 32.23% | 31.68% | 13.82% | 0.84x | |
| 6.12TCr | 6.91% | 38.79% | 64,669.09% | 13.22% | 2.44x | |
| 7.76TCr | 20.94% | 35.49% | 47.65% | 15.43% | 0.66x | |
| 5.87TCr | 17.41% | 31.46% | 31.99% | 13.12% | 1.2x | |
| 5.67TCr | 24.64% | 38.62% | 38.4% | 16.33% | 1.02x | |
| 4.86TCr | 33.14% | 41.3% | 60.7% | 20.31% | 0.69x | |
| 3.68TCr | 20.98% | 44.09% | 162.88% | 12.98% | 2.13x | |
| 2.94TCr | 28.9% | 44.81% | 48.87% | 17.34% | 1.08x | |
| 6.26TCr | 12.42% | 35.11% | 21.07% | 8.73% | 1.79x | |
| 1.2TCr | 32.94% | 43.85% | 27.07% | 16.41% | -1.21x | |
| 4.82TCr | 14.64% | 30.37% | 72.08% | 7.72% | 1.83x | |
| 4.4TCr | 17.5% | 29.95% | 46.39% | 9.48% | 1.28x | |
| 5.12TCr | 17.91% | 27.85% | 10.5% | 6.02% | 0.81x | |
| 802.29Cr | 34.5% | 47.6% | 22.1% | 25.56% | -0.66x | |
| 5.35TCr | -7.94% | 11.21% | 16.66% | -3.36% | 4.79x | |
| 452.21Cr | 24.38% | 28.42% | 14.26% | 12.85% | -4.14x | |
| 2.83TCr | 4.26% | 9.07% | -2.1% | 1.29% | -3.38x | |
| 1.48TCr | 15.11% | 22.9% | 10.23% | 4.98% | 2.56x | |
| Average | 4.28TCr | 19.88% | 33% | 3,272.95% | 12.49% | 0.75x | |
| Weighted average by Cap. | 5.98TCr | 23.47% | 37.02% | 6,522.03% | 15.78% | 1.10x |
- Stock Market
- Stocks
- ROVI Stock
- Sector Laboratorios Farmaceuticos Rovi, S.A.
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
